Thymogen, Oglufanide, 38101-59-6
1 Inquiries
38101-59-6
Reagent Grade
98%
shanghai
PEP091
1g/vial
2029-12-31
Cagrilintide,SS-31, Elamipretide,Semaglutide,Tirzepatide,Retatrutide
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionECHEMI Editorial ReferenceSolid
Glu-Trp is a dipeptide composed of L-glutamic acid and L-tryptophan joined by a peptide linkage. It has a role as a metabolite, an immunomodulator, an angiogenesis modulating agent and an antineoplastic agent. It derives from a L-glutamic acid and a L-tryptophan.|Oglufanide is a synthetic dipeptide immunomodulator in development for the treatment of chronic hepatitis C viral infection. Oglufanide was originally developed to treat severe infectious disease in Russia (where it is a registered pharmaceutical), and was extensively studied in cancer clinical trials in the United States before being acquired by Implicit Bioscience in 2005. Oglufanide works as a regulator of the body's immune response, is being given by intranasal administration to patients with chronic hepatitis C viral infection.
ChEBI: A dipeptide composed of L-glutamic acid and L-tryptophan joined by a peptide linkage.Basic Info-
Product Name:
H-GLU-TRP-OH
Other Name:alpha-glutamyltryptophan;GLU-TRP;H-GLU-TRP-OH;Ccris 8677;Glutamyl tryptophan;Glutamyltryptophan;L-alpha-Glutamyl-L-tryptophan;L-Tryptophan, N-L-alpha-glutamyl-
CAS No.:38101-59-6
Molecular Formula:C16H19N3O5
InChIKeys:LLEUXCDZPQOJMY-PZILLZCRNA-N
Molecular Weight:333.34
Exact Mass:333.34
UNII:4RHY598T5U
Color/Form:White to off-white
Categories:
Characteristics-
PSA:
146 Ų
XLogP3:1.56310
Density:1.428
Melting Point:121-122℃
Boiling Point:738.9±60.0 °C(Predicted)
PKA:3.09±0.10(Predicted)
Critical Temperature & Pressure:Keep in dark place,Inert atmosphere,2-8°C
-
-
Seller Information
-
Business Type:
Trader
-
Main Products:
Cagrilintide,SS-31, Elamipretide,Semaglutide,Tirzepatide,Retatrutide
-
Location:
Room C608, Chiyuan venture park
-
Payment Terms:
TT against copy of documents,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$5 million-$10 million
-
Total Employees:
11-50
Cellmano Biotech Limited focus on researching and developing solid phase peptide synthesis methodology since 2011. Cellmano has 10 years experience in researching, developing and manufacturing peptides by solid peptide phase synthesis.
Cellmano not only provides cosmeceuticals peptide & generic peptides to the customers, but also offer peptide CMO service and custom peptides synthesis service depend on the requirement from the customers over the world. Cellmano has state-of-the-art labs armed with excellent instrument for synthesis, purify and analysis .Cellmao control the quality by checking the materials, supervising produce process and finally QC. Cellmano keep all the synthesis records , purify methods and analysis result for every batch peptide product with staff and time invovled in the archives. Synthesizing by classical solid phase mothed invented by Prof.Bruce Merrified and purifying by HPLC instrument, Cellmano supply the customers excellent peptide products with reasonable price ,while maintain high quality, to help the customers to cut down their cost and shorten the time . Cellmano is trying her best to complement the inventory for more than 2000 popular peptide products, to make sure the customers can get what they need in one week from Cellmano’s inventory. Also to saitisfy diverse request from different customers for different projects, Cellmano provide custom synthesis for peptides from mgs to kgs with the purity from crude to 98% .
-
-
Inquiry History1 Inquiries
Country Product Purchase Quantity Date Posted
United States
thymogen
20 MG Mar 9, 2026 Post an enquiry for this product